Litcius/Paper detail

Reversible primary adrenal insufficiency related to anti-programmed cell-death 1 protein active immunotherapy: Insight into an unforeseen outcome of a rare immune-related adverse event

Maria V. Deligiorgi, Dimitrios T. Trafalis

2020International Immunopharmacology16 citationsDOI

Topics & Concepts

MedicineNivolumabHyponatremiaAdrenal insufficiencyHydrocortisoneImmune systemPrimary Adrenal InsufficiencyAdverse effectHyperkalemiaMineralocorticoidInternal medicineImmunotherapyImmunologyGlucocorticoidNeuroblastoma Research and TreatmentsAdrenal Hormones and DisordersCancer Immunotherapy and Biomarkers
Reversible primary adrenal insufficiency related to anti-programmed cell-death 1 protein active immunotherapy: Insight into an unforeseen outcome of a rare immune-related adverse event | Litcius